Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Autodesk Inc (ADSK) vs BridgeBio Pharma Inc (BBIO) Price & Performance

Autodesk IncTrade
BridgeBio Pharma IncTrade

Price performance (Past 24H)

Key statistics

Autodesk Inc vs BridgeBio Pharma Inc — how do they compare? Autodesk Inc trades at $247.5 (market cap $54.07B), while BridgeBio Pharma Inc trades at $83.9 (market cap $16.61B). The key difference: Autodesk Inc is far larger — about 3.3× BridgeBio Pharma Inc's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Autodesk Inc nearer its low. Which is the better fit depends on your goals.

ADSKBBIO
Market Cap
$54.07B$16.61B
Sector
TechnologyHealth
52-Week High
$326.79$90.17
52-Week Low
$187.72$47.29
Enterprise Value
$53.87B$18.16B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Autodesk Inc

Founded in 1982, Autodesk is an application software company that serves industries in architecture, engineering, and construction.

Read more on ADSK

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Read more on BBIO